$2.33T
Total marketcap
$83.77B
Total volume
BTC 50.09%     ETH 15.33%
Dominance

Telo Genomics TDSGF Stock

0.14 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
10.68M USD
LOW - HIGH [24H]
0.14 - 0.14 USD
VOLUME [24H]
7.88K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.04 USD

Telo Genomics Price Chart

Telo Genomics TDSGF Financial and Trading Overview

Telo Genomics stock price 0.14 USD
Previous Close 0.24 USD
Open 0.23 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.21 - 0.23 USD
52 Week Range 0.13 - 0.32 USD
Volume 29K USD
Avg. Volume 3.86K USD
Market Cap 15.99M USD
Beta (5Y Monthly) 1.96681
PE Ratio (TTM) N/A
EPS (TTM) -0.04 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

TDSGF Valuation Measures

Enterprise Value 12.75M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 16.05
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -4.898

Trading Information

Telo Genomics Stock Price History

Beta (5Y Monthly) 1.96681
52-Week Change 4.65%
S&P500 52-Week Change 20.43%
52 Week High 0.32 USD
52 Week Low 0.13 USD
50-Day Moving Average 0.21 USD
200-Day Moving Average 0.22 USD

TDSGF Share Statistics

Avg. Volume (3 month) 3.86K USD
Avg. Daily Volume (10-Days) 13.71K USD
Shares Outstanding 71.16M
Float 53.89M
Short Ratio N/A
% Held by Insiders 6.65%
% Held by Institutions 1.83%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:5

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End June 30, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -76.17%
Return on Equity (ttm) -129.42%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -2603877 USD
Net Income Avi to Common (ttm) -2619131 USD
Diluted EPS (ttm) -0.04
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 727.58K USD
Total Cash Per Share (mrq) 0.01 USD
Total Debt (mrq) 40K USD
Total Debt/Equity (mrq) 4.9 USD
Current Ratio (mrq) 7.173
Book Value Per Share (mrq) 0.014

Cash Flow Statement

Operating Cash Flow (ttm) -2790161 USD
Levered Free Cash Flow (ttm) -1568996 USD

Profile of Telo Genomics

Country United States
State ON
City Toronto
Address MaRS Centre
ZIP M5G 1L7
Phone N/A
Website https://www.telodx.com
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees N/A

Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncogenic and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves healthcare professionals, drug developers, and clinical researchers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. Telo Genomics Corp. was incorporated in 2014 and is headquartered in Toronto, Canada.

Q&A For Telo Genomics Stock

What is a current TDSGF stock price?

Telo Genomics TDSGF stock price today per share is 0.14 USD.

How to purchase Telo Genomics stock?

You can buy TDSGF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Telo Genomics?

The stock symbol or ticker of Telo Genomics is TDSGF.

Which industry does the Telo Genomics company belong to?

The Telo Genomics industry is Diagnostics & Research.

How many shares does Telo Genomics have in circulation?

The max supply of Telo Genomics shares is 75.96M.

What is Telo Genomics Price to Earnings Ratio (PE Ratio)?

Telo Genomics PE Ratio is now.

What was Telo Genomics earnings per share over the trailing 12 months (TTM)?

Telo Genomics EPS is -0.04 USD over the trailing 12 months.

Which sector does the Telo Genomics company belong to?

The Telo Genomics sector is Healthcare.